Cytotoxic T-cell and NK-cell lymphomas: Current questions and controversies

American Journal of Surgical Pathology

Volumn 38, Issue 10, 2014, Pages e60-e71

  Swerdlow, Steven H ^a,j   Jaffe, Elaine S ^b   Brousset, Pierre ^e   Chan, John K C ^g   De Leval, Laurence ^h   Gaulard, Philippe ^f   Harris, Nancy Lee ^c   Pileri, Stefano ⁱ   Weiss, Lawrence M ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GE HEALTHCARE   (United States)

^e IUCT Oncopole   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

more..

Author keywords

Cytotoxic T cell lymphoma; Enteropathy associated T cell lymphoma; Natural killer cells; T cells

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR MARKER;

BIOPSY; CELL LINEAGE; CLASSIFICATION; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL DIAGNOSIS; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; EPSTEIN BARR VIRUS; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; NATURAL KILLER CELL; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVIEW; T CELL LYMPHOMA; VIROLOGY;

BIOPSY; CELL LINEAGE; DIAGNOSIS, DIFFERENTIAL; ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84908568987     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000295     Document Type: Review

References (100)

1. Kato S, Takahashi E, Asano N, et al. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Histopathology. 2012;61:186-199.
2. Tripodo C, Iannitto E, Florena AM, et al. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol. 2009;6:707-717.
3. Kindt TJ, Goldsby RA, Osborne BA. Kuby Immunology. New York: W.H. Freeman & Co; 2007.
4. Wencker M, Turchinovich G, Di Marco Barros R, et al. Innate-like T cells straddle innate and adaptive immunity by altering antigenreceptor responsiveness. Nat Immunol. 2014;15:80-87.
5. Ciofani M, Knowles GC, Wiest DL, et al. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity. 2006;25:105-116.
6. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10:467-478.
7. O'Brien RL, Born WK. gammadelta T cell subsets: a link between TCR and function? Semin Immunol. 2010;22:193-198.
8. Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat Rev Immunol. 2011;11:645-657.
9. Brown DM. Cytolytic CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol. 2010;262:89-95.
10. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas. Am J Pathol. 1990;137:617-628.
11. Rodriguez-Pinilla SM, Ortiz-Romero PL, Monsalvez V, et al. TCR-gamma expression in primary cutaneous T-cell lymphomas. Am J Surg Pathol. 2013;37:375-384.
12. Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011;25:348-358.
13. Willemze R, Jansen PM, Cerroni L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111:838-845.
14. Jaffe ES, Gaulard P, Ralfkiaer E, et al. Subcutaneous panniculitislike T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:294-295.
15. Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101:3407-3412.
16. Guitart J, Weisenburger DD, Subtil A, et al. Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol. 2012;36:1656-1665.
17. Endly DC, Weenig RH, Peters MS, et al. Indolent course of cutaneous gamma-delta T-cell lymphoma. J Cutan Pathol. 2013;40:896-902.
18. Magro CM, Wang X. Indolent primary cutaneous gamma/delta T-cell lymphoma localized to the subcutaneous panniculus and its association with atypical lymphocytic lobular panniculitis. Am J Clin Pathol. 2012;138:50-56.
19. Quintanilla-Martinez L, Jansen PM, Kinney MC, et al. Nonmycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139:491-514.
20. Attygalle AD, Cabecadas J, Gaulard P, et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014;64:171-199.
21. Kempf W, Kazakov DV, Scharer L, et al. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Am J Surg Pathol. 2013;37:1-13.
22. Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119:673-686.
23. Travert M, Huang Y, de Leval L, et al. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood. 2012;119:5795-5806.
24. Macon WR, Levy NB, Kurtin PJ, et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol. 2001;25:285-296.
25. Garcia-Herrera A, Song JY, Chuang SS, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol. 2011;35:1214-1225.
26. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood. 1998; 91:1723-1731.
27. Chan JK, Chan AC, Cheuk W, et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol. 2011;35:1557-1569.
28. Wilson AL, Swerdlow SH, Przybylski GK, et al. Intestinal gammadelta T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol. 2013;44:1131-1145.
29. Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36:481-499.
30. Quintanilla-Martinez L, Ridaura C, Nagl F, et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122:3101-3110.
31. Przybylski GK, Wu H, Macon WR, et al. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn. 2000;2:11-19.
32. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol. 2007;38:1293-1304.
33. Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37:14-23.
34. Mori N, Yamashita Y, Tsuzuki T, et al. Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology. 2000;37:363-371.
35. Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV+ T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:278-280.
36. Ohshima K, Suzumiya J, Sugihara M, et al. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types. Virchows Arch. 1999;435:92-100.
37. Anagnostopoulos I, Hummel M, Stein H. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leuk Lymphoma. 1995;19:1-12.
38. Zhou XG, Hamilton-Dutoit SJ, Yan QH, et al. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology. 1994;24:115-122.
39. Ohshima K, Liu Q, Koga T, et al. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma-natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch. 2002;440:425-435.
40. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta Tcell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261-4269.
41. Tan SY, Nakamura S, Tan HC, et al. Diagnosis of type II enteropathy-associated T-cell lymphoma should be limited to EBER-cases. Am J Hematol. 2012;87:E129-E130.
42. Tse E, Gill H, Loong F, et al. Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol. 2012;87:663-668.
43. Mitarnun W, Saechan V, Pradutkanchana J, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma with gastrointestinal tract involvement. J Med Assoc Thai. 2003;86:816-828.
44. Lavergne A, Brocheriou I, Delfau MH, et al. Primary intestinal gamma-delta T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology. 1998;32:271-276.
45. de Bruin PC, Jiwa NM, Oudejans JJ, et al. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype. Am J Pathol. 1995;146:861-867.
46. Pan L, Diss TC, Peng H, et al. Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL). J Pathol. 1993;170:137-143.
47. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood. 1997;89:644-651.
48. Zhang WY, Li GD, Liu WP, et al. Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection. Chin Med J. 2005;118:1542-1548.
49. Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al. Primary intestinal non-Hodgkin's lymphoma and Epstein-Barr virus: high frequency of EBV-infection in T-cell lymphomas of Mexican origin. Leuk Lymphoma. 1998;30:111-121.
50. Chuang SS, Jung YC. Natural killer cell lymphoma of small intestine with features of enteropathy but lack of association with celiac disease. Hum Pathol. 2004;35:639-642.
51. de Bruin PC, Connolly CE, Oudejans JJ, et al. Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype. Histopathology. 1997;31:313-317.
52. Walsh SV, Egan LJ, Connolly CE, et al. Enteropathy-associated Tcell lymphoma in the West of Ireland: low-frequency of Epstein-Barr virus in these tumors. Mod Pathol. 1995;8: 753-757.
53. Korbjuhn P, Anagnostopoulos I, Hummel M, et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood. 1993;82:217-223.
54. Isaacson PG. Intestinal lymphoma and enteropathy. J Pathol. 1995;177:111-113.
55. Ilyas M, Niedobitek G, Agathanggelou A, et al. Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma. J Pathol. 1995;177:115-122.
56. Porcu P, Caligiuri M. A sheep in wolf's clothing. Blood. 2011;117:1438-1439.
57. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010;34: 405-417.
58. Novelli M, Merlino C, Ponti R, et al. Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood. J Invest Dermatol. 2009;129:1556-1561.
59. Park S, Lee DY, Kim WS, et al. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course. Am J Dermatopathol. 2010;32:832-836.
60. Choi YL, Park JH, Namkung JH, et al. Extranodal NK/T-cell lymphoma with cutaneous involvement:'nasal' vs. 'nasal-type' subgroups-a retrospective study of 18 patients. Br J Dermatol. 2009;160:333-337.
61. Yu JB, Zuo Z, Tang Y, et al. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Hum Pathol. 2009;40:807-816.
62. Gaulard P, Berti E, Willemze R, et al. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:302-305.
63. Toro JR, Beaty M, Sorbara L, et al. gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol. 2000;136:1024-1032.
64. Caudron A, Bouaziz JD, Battistella M, et al. Two atypical cases of cutaneous gamma/delta T-cell lymphomas. Dermatology. 2011;222:297-303.
65. Yu WW, Hsieh PP, Chuang SS. Cutaneous EBV-positive gammadelta T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review. J Cutan Pathol. 2013;40:310-316.
66. Vazquez A, Khan MN, Blake DM, et al. Extranodal natural killer/T-Cell lymphoma: a population-based comparison of sinonasal and extranasal disease. Laryngoscope. 2014;124:888-895.
67. Kim SJ, Jung HA, Chuang SS, et al. Extranodal natural killer/Tcell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group. J Hematol Oncol. 2013;6:86.
68. Carey MJ, Medeiros LJ, Roepke JE, et al. Primary anaplastic large cell lymphoma of the small intestine. Am J Clin Pathol. 1999;112:696-701.
69. Ross CW, Hanson CA, Schnitzer B. CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma. Cancer. 1992;70:2517-2523.
70. Sun J, Zhou JL, Chen J, et al. Clinicopathologic features of gastrointestinal tract involvement of anaplastic large cell lymphoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012;34:228-233.
71. ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. J Clin Pathol. 2000;53:445-450.
72. Kagami Y, Suzuki R, Taji H, et al. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients. Am J Surg Pathol. 1999;23:1184-1200.
73. Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol. 1999;154:1203-1210.
74. Aung PP, Climent F, Muzzafar T, et al. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol. 2014;41:51-57.
75. Petrella T, Maubec E, Cornillet-Lefebvre P, et al. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma? Am J Surg Pathol. 2007;31: 1887-1892.
76. Beltraminelli H, Mullegger R, Cerroni L. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma? J Cutan Pathol. 2010;37:81-84.
77. Suchak R, O'Connor S, McNamara C, et al. Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-/medium-sized pleomorphic T-cell lymphoma or a distinct entity? J Cutan Pathol. 2010;37:977-981.
78. Swick BL, Baum CL, Venkat AP, et al. Indolent CD8+ lymphoid proliferation of the ear: report of two cases and review of the literature. J Cutan Pathol. 2011;38:209-215.
79. Zeng W, Nava VE, Cohen P, et al. Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases. J Cutan Pathol. 2012;39:696-700.
80. Kempf W, Kazakov DV, Cozzio A, et al. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification. Am J Dermatopathol. 2013;35:159-166.
81. Greenblatt D, Ally M, Child F, et al. Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features. J Cutan Pathol. 2013; 40:248-258.
82. Fika Z, Karkos PD, Badran K, et al. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear. J Laryngol Otol. 2007;121:503-505.
83. Gormley RH, Hess SD, Anand D, et al. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma. J Am Acad Dermatol. 2010;62:300-307.
84. Mansoor A, Pittaluga S, Beck PL, et al. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447-1452.
85. Takeuchi K, Yokoyama M, Ishizawa S, et al. Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116: 5631-5637.
86. Terai T, Sugimoto M, Uozaki H, et al. Lymphomatoidgastropathy mimicking extranodal NK/T cell lymphoma, nasal type: a case report. World J Gastroenterol. 2012;18:2140-2144.
87. Perry AM, Warnke RA, Hu Q, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 2013; 122:3599-3606.
88. Margolskee E, Jobanputra V, Lewis SK, et al. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One. 2013;8:e68343.
89. Carbonnel F, d'Almagne H, Lavergne A, et al. The clinicopathological features of extensive small intestinal CD4 T cell infiltration. Gut. 1999;45:662-667.
90. Asano N, Suzuki R, Kagami Y, et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol. 2005;29:1284-1293.
91. Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026-1036.
92. Hartmann S, Agostinelli C, Klapper W, et al. Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? Histopathology. 2011;59:1173-1182.
93. Geissinger E, Odenwald T, Lee SS, et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells. Virchows Arch. 2004;445:334-343.
94. Rodriguez-Pinilla SM, Atienza L, Murillo C, et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol. 2008;32:1787-1799.
95. Kagami Y, Sobue R, Ito N, et al. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56-phenotype, and its relation to Epstein-Barr virus: a report of two cases. Int J Hematol. 1999;70:105-111.
96. Mukai HY, Hasegawa Y, Kojima H, et al. Nodal CD8 positive cytotoxic T-cell lymphoma: a distinct clinicopathological entity. Mod Pathol. 2002;15:1131-1139.
97. Kitamura A, Yamashita Y, Sato Y, et al. Aggressive Lennert's lymphoma: report of three cases in comparison to non-aggressive Lennert's lymphoma. Pathol Int. 2005;55:626-631.
98. Müller-Hermelink H, Delabie J, Ko Y, et al. T-cell lymphoma of the small intestine. In: Bosman F, Carneiro F, Hruban R, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010:112-114.
99. Tan SY, Chuang SS, Tang T, et al. Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype. Leukemia. 2013; 27:1688-1696.
100. Isaacson PG, Chott A, Ott G, et al. Enteropathy-associated T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:289-291.